Pipecolic acid induces apoptosis in neuronal cells

Brain Research

Volumn 980, Issue 2, 2003, Pages 179-184

  Matsumoto, Shinji ^a,b   Yamamoto, Satoshi ^a   Sai, Katsunari ^a   Maruo, Keishi ^a   Adachi, Masaru ^a   Saitoh, Masaru ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell death; Hepatic encephalopathy; Ion channel; Neurotransmission; Pipecolic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BIOCHEMICAL MARKER; CALCIUM CHANNEL; HOE 33342; ION CHANNEL; PIPECOLIC ACID; POTASSIUM CHANNEL; PROPIDIUM IODIDE; SODIUM CHANNEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CELL ASSAY; CELL DEATH; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; EMBRYO; EXCITATORY POSTSYNAPTIC POTENTIAL; FLUORESCENCE MICROSCOPY; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; INHIBITION KINETICS; MEMBRANE CURRENT; MOUSE; NERVE CELL; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; VOLTAGE CLAMP;

EID: 0038303535     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02869-5     Document Type: Article

References (25)

1. Bietz A.J., Larson A.A. Inhibition of intrathecally administered picrotoxin- and bicuculline-induced convulsions in mice by pipecolic acid or GABA. Eur. J. Pharmacol. 114:1985;181-187.
2. Chang Y.F. Pipecolic acid pathway: the major lysine metabolic route in the rat brain. Biochem. Biophys. Res. Commun. 69:1976;174-189.
3. Chang Y.F. Lysine metabolism in the rat brain: blood-brain barrier transport, formation of pipecolic acid and human hyperpipecolatemia. J. Neurochem. 30:1978;355-360.
4. Charles A.K. Pipecolic acid receptors in rat cerebral cortex. Neurochem. Res. 11:1986;521-525.
5. Dancis J., Hutzler J. The metabolism of L- and D-pipecolic acid in the rabbit and rat. Biochim. Biophys. Acta. 675:1981;411-415.
6. Danks D.M., Tippett P., Adams C., Campbell P. Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J. Pediatr. 86:1975;382-387.
7. Fujita T., Amuro Y., Hada T., Higashino K. Plasma levels of pipecolic acid, both L- and D-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy. Clin. Chim. Acta. 287:1999;99-109.
8. Fujita T., Hada T., Higashino K. Origin of L- and D-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test. Clin. Chim. Acta. 287:1999;145-156.
9. Gatfield P.D., Taller E., Hinton G.G., Wallace A.C., Abdelnour G.M., Haust M.D. Hyperpipecolatemia: a new metabolic disorder associated with neuropathy and hepatomegaly: a case study. Can. Med. Assoc. J. 99:1968;1215-1233.
10. Giacobini E., Nomura Y., Schmidt-Glenewinkel T. Pipecolic acid: origin, biosynthesis and metabolism in the brain. Cell. Mol. Biol. 26:1980;135-146.
11. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int. J. Oncol. 22:2003;15-20.
12. 3H] GABA from brain slices of mouse cerebral cortex. Neurochem. Res. 14:1989;405-408.
13. Kase Y., Takahama K., Hashimoto T., Kaisaku J., Okano Y., Miyata T. Electrophoretic study of pipecolic acid, a biogenic imino acid, in the mammalian brain. Brain Res. 193:1980;608-613.
14. Kawasaki H., Hori T., Nakajima M., Takeshita K. Plasma levels of pipecolic acid in patients with chronic liver disease. Hepatology. 8:1988;286-289.
15. Matsuda Y., Fujita T., Hada T., Higashino K. Comparative study on the correlation of plasma γ-aminobutyric acid and pipecolic acid with liver function in patients with liver cirrhosis. Hepatol. Res. 18:2000;132-140.
16. Mullen K.D., Szauter K.M., Russ K.K. 'Endogenous' benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet. 336:1990;81-83.
17. Nomura Y., Okuma Y., Segawa T., Schmidt-Glenewinkel T., Giacobini E.G. A calcium-dependent, high potassium-induced release of pipecolic acid from rat brain slices. J. Neurochem. 33:1979;803-805.
18. Nomura Y., Okuma Y., Segawa T., Schmidt-Glenewinkel T., Giacobini E. Comparison of synaptosomal and glial uptake of pipecolic acid and GABA in rat brain. Neurochem. Res. 6:1981;391-400.
19. Nomura Y., Schmidt-Glenewinkel T., Giacobini E. Uptake of piperidine and pipecolic acid by synaptosomes from mouse brain. Neurochem. Res. 5:1980;1163-1173.
20. Norenberg M.D. Astroglial dysfunction in hepatic encephalopathy. Metab. Brain Dis. 13:1998;319-335.
21. Takahama K., Hashimoto T., Wang M.W., Akaike N., Hitoshi T., Okano Y., Kase Y., Miyata T. Pipecolic acid enhancement of GABA response in single neurons of rat brain. Neuropharmacology. 25:1986;339-342.
22. Takahama K., Miyata T., Hashimoto T., Okano Y., Hitoshi T., Kase Y. Pipecolic acid: a new type of α-amino acid possessing bicuculline-sensitive action in the mammalian brain. Brain Res. 239:1982;294-298.
23. Thomas G.H., Haslam R.H., Batshaw M.L., Capute A.J., Neidengard L., Ransom J.L. Hyperpipecolic acidemia associated with hepatomegaly, mental retardation, optic nerve dysplasia and progressive neurological disease. Clin. Genet. 8:1975;376-382.
24. Trijbels J.M., Monnens L.A., Melis G., van den Broekvan Essen M., Bruckwilder M. Localization of pipecolic acid metabolism in rat liver peroxisomes: probable explanation for hyperpipecolataemia in Zellweger syndrome. J. Inherit. Metab. Dis. 10:1987;128-134.
25. Woody N.C., Pupene M.B. Excretion of pipecolic acid by infants and by patients with hyperlysinemia. Pediatr. Res. 4:1970;89-95.